title: Atherosclerosis in haemodialysis patients without significant comorbidities: determinants of progression.
abstract: OBJECTIVE
  The aim of this prospective study was to assess the determinants of the progression of carotid artery intima-media thickness (CA-IMT) for 1 year in haemodialysis (HD) patients without significant comorbidities.
  
  
  METHODS
  Fifty-four HD patients younger than 55 years, without diabetes, obesity and any clinical evidence of cardiovascular disease (29 men, 25 women; mean age 33.3 +/- 10 years; mean time on HD 49.4 +/- 43 months) were included in the 1-year study. CA-IMT was assessed at baseline and after 12 months. The difference in IMT between these two points of time was calculated (DeltaCA-IMT). C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), haematocrit-corrected ESR, beta-2 microglobulin, cardiac troponin I, lipid profile, fibrinogen, homocysteine, CaXP product, intact parathyroid hormone, haematocrit, albumin, uric acid levels, anthropometric parameters (age, body mass index), smoking, hypertension and left ventricular hypertrophy were recorded at baseline.
  
  
  RESULTS
  The mean value for CA-IMT at baseline (0.59 +/- 0.05 mm) was significantly lower than that at 12 months (0.64 +/- 0.07 mm) (P < 0.001). CA-IMT had increased in 41 patients (75.9%). Age (P = 0.02), CRP (P = 0.03), beta-2 microglobulin (P = 0.001) and left ventricular hypertrophy (P = 0.01) were independently related with CA-IMT at baseline. Age (P = 0.003) and CRP (P = 0.04) were the independent variables related with CA-IMT, measured at 12 months. DeltaCA-IMT correlated positively with age (r = 0.31, P < 0.05). Age and sex were independent predictors of DeltaCA-IMT (R(2) for the model 0.56).
  
  
  CONCLUSIONS
  In addition to age and male sex, non-specific inflammation may have a possible role in the progression of atherosclerosis in HD patients without significant comorbidities.
authors.affiliation: Department of Nephrology, Baskent University, Faculty of Medicine, Ankara, Turkey. azumrutdal@yahoo.com
authors.forename: Aysegul
authors.initials: A
authors.lastname: Zumrutdal
authors.forename: Senol
authors.initials: S
authors.lastname: Demircan
authors.forename: Gulsah
authors.initials: G
authors.lastname: Seydaoglu
authors.forename: Metin
authors.initials: M
authors.lastname: Singan
authors.forename: Siren
authors.initials: S
authors.lastname: Sezer
authors.forename: F Nurhan
authors.initials: FN
authors.lastname: Ozdemir
authors.forename: Mehmet
authors.initials: M
authors.lastname: Haberal
mesh_terms: D000328:Adult; D017677:Age Distribution; D050197:Atherosclerosis / Q000000981:diagnostic imaging / Q000453:epidemiology*; D002097:C-Reactive Protein / Q000378:metabolism; D002339:Carotid Arteries / Q000000981:diagnostic imaging; D015897:Comorbidity; D018450:Disease Progression; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000453:epidemiology* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D006435:Renal Dialysis / Q000706:statistics & numerical data*; D012307:Risk Factors; D017678:Sex Distribution; D017539:Tunica Intima / Q000000981:diagnostic imaging; D017540:Tunica Media / Q000000981:diagnostic imaging; D014463:Ultrasonography; D014657:Vasculitis / Q000453:epidemiology
chemical_list: D002097:C-Reactive Protein